ClinicalTrials.gov
public full text
Public Domain
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI), (done before, during, and after treatment) may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This phase II trial is studying how well MRI and MRSI evaluate patients who are undergoing treatment for gliomas.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality#1029734
- Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas#910296
- Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams#1352238
- Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging#893075
- Magnetic Resonance Imaging and Spectroscopy at High Field#968208
Record · ID 1446486
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive